Scope
Research payments
$16,348,137
Through program year 2023, $16,348,137 in research payments was reported against Scope, across 483 payments, paid by Partner Therapeutics, Inc..
- Paid by
- Partner Therapeutics, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $1,050 | 1 |
| 2022 | Research | $11,898,819 | 234 |
| 2021 | Research | $4,448,268 | 248 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Narinder Saini Springfield, OH Named on 41 payments
- Rodolfo Perez Hialeah, FL Named on 31 payments
- Sandro Bacchelli Hollywood, FL Named on 27 payments
- Steve Choi Dayton, OH Named on 26 payments
- Jeffrey Zacher Phoenix, AZ Named on 24 payments
- Joseph Varon Houston, TX Named on 21 payments
- Jose Cardona Miami, FL Named on 20 payments
- Duane Anderson Las Vegas, NV Named on 20 payments
- Lee Wilbur Indianapolis, IN Named on 16 payments
- Bernard Garcia Fort Lauderdale, FL Named on 16 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.